SA57 is a potent and selective inhibitor of fatty acid amide hydrolase (FAAH), with IC50 values of 3.2 nM and 1.9 nM against mouse and human FAAH, respectively. It also inhibits monoacylglycerol lipase (MAGL) (IC50 = 410 nM for mouse and 1.4 μM for human) and mouse α/β-hydrolase domain-containing protein 6 (ABHD6; IC50 = 850 nM), but does not inhibit other brain serine hydrolases. SA57 exhibits time-dependent, irreversible inhibition of FAAH and MAGL, likely through carbamylation of the active site serine nucleophiles of these enzymes. In vivo, SA57 (0.01–12.5 mg/kg, intraperitoneal injection, 2 hours) demonstrates dose-dependent inhibition of brain serine hydrolases, including FAAH, MAGL, and ABHD6, in C57Bl/6 mice.